Comparison of the distribution of progenitor cells in G-CSF-mobilized peripheral blood and steady-state bone marrow after counterflow centrifugal elutriation

Biology of Blood and Marrow Transplantation

Volumn 5, Issue 5, 1999, Pages 328-335

  Chang, Qing ^a   Harvey, Kevin ^a   Akard, Luke ^a   Thompson, James ^a   Hanks, Susan ^a   Dugan, Michael ^a   Jansen, Jan ^a,b  

^a METHODIST HOSPITAL   (United States)

^b Indiana Blood and Marrow Transplantation   (United States)

Author keywords

Bone marrow; CD34; Elutriation; Peripheral blood; Stem cells

Indexed keywords

CD11 ANTIGEN; CD15 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BLOOD; BONE MARROW CELL; CELL SEPARATION; CENTRIFUGATION; COMPARATIVE STUDY; CYTAPHERESIS; DRUG EFFECT; HUMAN; IMMUNOLOGY; METHODOLOGY; STEM CELL; STEM CELL MOBILIZATION;

ADULT; ANTIGENS, CD11; ANTIGENS, CD15; ANTIGENS, CD3; ANTIGENS, CD34; BONE MARROW CELLS; CELL SEPARATION; CENTRIFUGATION; CYTAPHERESIS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; STEM CELLS;

EID: 0032613785     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(99)70009-1     Document Type: Article

References (33)

1. To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 89:2233, 1997.
2. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maber D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992.
3. Schmitz N, Dreger P, Suttorp M, Robwedder EB, Haferlach T, Loffer H, Hunter A, Russell N: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995.
4. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick A, Moubayed M, Oldham F, Corringbam RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 85:275, 1995.
5. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 86:2842, 1995.
6. Grigg AP, Roberts AW, Raunows H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D: Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86:4437, 1995.
7. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995.
8. Korbling M, Przepiorka D, Hub YO, Engel D, Van Besien K, Giraff S, Andersson B, Kleine HD, Seong D, Deisserotb AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85:1659, 1995.
9. Russell N, Gratwohl A, Schmitz N: The place of blood stem cells in allogeneic transplanttaion. Brit J Haematol 93:7547, 1996.
10. Ustun C, Arslan O, Beksac M, Koc H, Gurman G, Ozcelik T, Yilmaz B, Ilban O, Akan H, Ozcan M, Demirer T, Uysal A, Konuk N, Arat M, Dilek I, Celebi H, Coskun HS: A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation from a single center: a focus on the incidence of graft-vs.-host disease and relapse. Biology Blood and Marrow Transplant 5:28, 1999.
11. Mitsuyasu RT, Champlin RE, Gale RP, Ho WG, Lenarsky C, Winston D, Selch M, Elashoff R, Giorgi JV, Wells J, Terasaki P, Billing R, Feig S: Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. Ann Int Med 105:20, 1986.
12. + CD8 depletion for patients at high risk for severe acute GVHD. Bone Marrow Transpl 17:377, 1996.
13. Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA, Gottschal JI, Oldbam K, Anderson T, Camitta B, Menitove J: Successful allogenic transplantation of T-cell depleted bone-marrow from closely HLA-matched unrelated donors. N Engl J Med 322:485, 1990.
14. Ahnici C, Donnenberg AD, Rizzoli V: Counterflow centrifugal elutriation: experimental and clinical applications. J Hematother 1:279, 1992.
15. De Witte T, Hoogenbout J, de Pauw B, Holdrinet R, Janssen J, Wessels J, van Daal W, Hustinx T, Haanen C: Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation. Blood 67:1302, 1986.
16. Schattenberg A, de Witte T, Preijers F, Raemakers J, Muus R, van der Lely N, Boezeman J, Wessels J, van Dijk B, Hoogenhout J, Haanen C: Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation. Blood 75:1356, 1990.
17. Wagner JE, Donnenberg AD, Noga SJ, Cremo CA, Gao IK, Yin HJ, Vogelsang GB, Rowley S, Saral R, Santos GW: Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial. Blood 72:1168, 1988.
18. Wagner JE, Santos GW, Noga SJ, Rowley SD, Davis J, Vogelsang GB, Farmer ER, Zehnbauer BA, Saral R, Donnenberg AD: Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial. Blood 75:1370, 1990.
19. Preijers F, Ruijs P, Schattenberg A, de Witte T: T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34 positive cells. In: DA Worthington-White, AP Gee, S Gross (eds) Advances in Bone Marrow Purging and Processing. New York: Wiley-Lee, 339, 1994.
20. Wagner JE, Collins D, Fuller S, Schain LR, Berson AE, Ahnici C, Hall MA, Chen KE, Okarma TB, Lebkowski JS: Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice. Blood 86:512, 1995.
21. + cells. Bone Marrow Transpl 19:1145, 1997.
22. + cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation. Exp Hematol 25:423, 1997.
23. Brandt J, Briddell RA, Srour EF, Leemhuis TB, Hoffman R: Role of c-kit ligand in the expansion of human hematopoietic cells. Blood 79:634, 1992.
24. Herbein G, Sovalat H, Wunder E, Baerenzung M, Bacborz J, Lewandowski H, Schweitzer C, Schmitt C, Kirn A, Henon P: Isolation and identification of two CD34 cell subpopulations from normal human peripheral blood. Stem Cells 12:187, 1994.
25. + bone marrow cells. Blood 84:1473, 1994.
26. Udomsakdi C, Lansdorp PM, Hogge DE, Reid DS, Eaves AC, Eaves CJ: Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood 80:2513, 1992.
27. Pettengell, R, Luft T, Henschler R, Hows JM, Dexter MT, Ryder D, Testa NG: Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord cells, and blood stem cells. Blood 84:3653, 1994.
28. Prosper F, Stroncek D, Verfaillie CM: Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. Blood 88:2033, 1996.
29. Prosper F, Vanoverbeke K, Stroncek D, Verfaillie CM: Primitive long-term culture-initiating cells (LTC-IC) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex-vivo expansion as primitive LTC-IC in steady state bone marrow. Blood 89:3991, 1997.
30. Meisenberg B, Brehm T, Schmeckel A, Miller W, McMillan R: A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost effective than granulocyte colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells. Transfusion 38:209, 1998.
31. + cell collections are not necessarily cost-effective. Blood 92:296b, 1998.
32. + cells. Blood 84:2930, 1994.
33. + selection systems or CAMPATH-1. Exp Hematol 23:147, 1995.